What Happened? Shares of healthcare services company Chemed Corporation (NYSE:CHE) jumped 8.8% in the afternoon session after the company reported first-quar...
Healthcare services company Chemed Corporation (NYSE:CHE) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 1.6% year on ye...
Healthcare services company Chemed Corporation (NYSE:CHE) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 1.6% year on year to $657.5 mil...
Healthcare services company Chemed Corporation (NYSE:CHE) will be announcing earnings results this Thursday after market close. Here’s what investors should ...
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Cas...
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the senior health, home health & hospice stocks, including Chemed (NYSE:CHE) and its pe...
The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whet...
Over the past six months, Chemed’s shares (currently trading at $402.72) have posted a disappointing 11.9% loss while the S&P 500 was flat. This was partly d...
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fea...
Shares of healthcare services company Chemed Corporation (NYSE:CHE)
fell 15.6% in the afternoon session after the company reported financial results for the fourth quarter of 2025 that missed Wall Street's expectations for both revenue and profit.
Healthcare services company Chemed Corporation (NYSE:CHE) fell short of the market’s revenue expectations in Q4 CY2025, with sales flat year on year at $639.3 million. Its non-GAAP profit of $6.42 per share was 8.7% below analysts’ consensus estimates.
A company that generates cash isn’t automatically a winner.
Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
Chemed trades at $473.22 per share and has stayed right on track with the overall market, gaining 6.4% over the last six months. At the same time, the S&P 500 has returned 6%.
While profitability is essential, it doesn’t guarantee long-term success.
Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately
as healthcare stocks have returned 18.6% over the past six months, topping the S&P 500 by 10.2 percentage points.
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on.
But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
Shares of healthcare services company Chemed Corporation (NYSE:CHE)
fell 4.2% in the afternoon session after Jefferies downgraded the stock to 'Hold' from 'Buy' and slashed its price target.
